Anti-Inflammatory Challenge in Schizophrenia — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Anti-Inflammatory Challenge in Schizophrenia — Stella

Recruiting

Back to Schizophrenia trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(2 sites)

United States

Grady Memorial Hospital, Atlanta, Georgia

Emory University Hospital, Atlanta, Georgia

Key details

Phase

Post-approval study

Sponsor

Emory University

Collaborators

National Institute of Mental Health (NIMH)

Enrollment target

~20 participants

Started

April 2024

Primary completion

March 2028

Age range

18 Years – 45 Years

Last updated April 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov